ARMP
Armata Pharmaceuticals
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Armata Pharmaceuticals received FDA Breakthrough Therapy Designation for AP-SA02Sep 14, 2026
- Armata Pharmaceuticals secures FDA Fast Track designation for AP-SA02May 7, 2026
- Armata Pharmaceuticals announces positive topline data from Phase 1b/2a diSArm study of intravenously administered AP-SA02 in complicated Staphylococcus aureus bacteremia.May 19, 2025